Beck Capital Management »

Vaneck Vectors Pharmaceutical etf shares owned by Beck Capital Management

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Beck Capital Management from 13F filings

Historical chart of Beck Capital Management investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Beck Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Beck Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 21k 90.70
2023-12-31 $1.6M 20k 81.37

More positions owned by Beck Capital Management

Nvidia Corporation Equity (NVDA)
Microsoft Corp Equity (MSFT)
Meta Platforms Inc Class A Equity (META)
Amazon.com Equity (AMZN)
Super Micro Computer Inc Com Usd0.001 Equity (SMCI)
Crowdstrike Hldgs Inc Cl A Equity (CRWD)
Blackstone Secd Lending Equity (BXSL)
Chipotle Mexican Grill Equity (CMG)
Invesco Exchange Traded Fd Tr Aerospace Defn Equity (PPA)
Eli Lilly &co Equity (LLY)
Spdr Ser Tr S&p Homebuild Equity (XHB)
Vertiv Holdings Co Com Cl A Equity (VRT)
J P Morgan Exchange Traded Fd Nasdaq Eqt Prem Equity (JEPQ)
Cameco Corp Com Npv Isin #ca13321l1085 Sedol #2166160 Equity (CCJ)
Invesco Exchange Traded Fd Tr S&p 100 Eql Wigh Equity (EQWL)

View all positions for Beck Capital Management

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Mirae Asset Global Investments
Miller Investment Management
Northwestern Mutual Wealth Management Company
Jpmorgan Chase & Co
Prime Capital Investment Advisors
Financial Partners Group
Mivtachim The Workers Social Insurance Fund
Bank of America Corporation
LPL Financial
Phoenix Holdings
Morgan Stanley
Adamsbrown Wealth Consultants

View all funds holding Vaneck Vectors Pharmaceutical etf